RRH brings new breast ultrasound system

Ridgecrest Regional Hospital, thanks in part to community-wide support to the Development Foundation, are now offering the Invenia automated breast ultrasound system to patients. The cutting-edge system is approved by the Federal Drug Administration for breast cancer screening as an adjunct to mammography for asymptomatic women with dense breast tissue and no prior interventions.

“We are excited to add the Automated Breast Ultrasound system from GE Healthcare to our comprehensive breast cancer screening program,” said RRH Chief Executive Officer James Suver. “By offering ABUS in addition to mammography for our patients with dense breast tissue, we anticipate improving detection for small cancers that cannot be seen on a mammogram alone in these women. We believe ABUS will become an integral part of our practice for the detection of breast cancer.”

“We are extremely grateful and thrilled to be a part of bringing new breast cancer detecting technology to the women of our community,” said Tamara Tilley, executive director of the Development Foundation.

“Our donors did not just give financially — they became investors in Ridgecrest Regional Hospital. Their donations are a gift to the community and speak volumes about their commitment to having the very best health care options right here in Ridgecrest.”

Dense breast tissue not only increases the risk of breast cancer up to 4-6 times but also makes cancer more difficult to detect using mammography, according to multiple large studies. One study, published in the New England Journal of Medicine, showed mammography sensitivity is reduced by 36 to 38 percent in women with dense breasts, as density masks the appearance of tumors.

As a result, several states, including California, have passed laws mandating that women be notified if their breasts are dense, and may offer supplemental imaging as appropriate.

Although mammography is an effective tool for the detection of breast cancer, it doesn’t work equally well in all women — particularly those with dense breast tissue, said a spokesperson. The ABUS has the potential to find 35.7 percent additional cancers that would not have been found with mammography alone.

The Invenia ABUS may also be used for diagnostic ultrasound imaging of the breast in symptomatic women. See the device manual for detailed information, contraindications, warnings, precautions, potential adverse events.

Story First Published: 2017-06-09